Cargando…
Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy
In the last 2 decades, health care management has been challenged by more aggressive therapy, the increased number of specialty medications, and more stringent guidelines to monitor adverse events or health risk. To promote patient safety, various communication requirements are mandated to increase...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437540/ https://www.ncbi.nlm.nih.gov/pubmed/22468736 http://dx.doi.org/10.18553/jmcp.2012.18.3.268 |
_version_ | 1785092548826497024 |
---|---|
author | Projects, AMCP Special |
author_facet | Projects, AMCP Special |
author_sort | Projects, AMCP Special |
collection | PubMed |
description | In the last 2 decades, health care management has been challenged by more aggressive therapy, the increased number of specialty medications, and more stringent guidelines to monitor adverse events or health risk. To promote patient safety, various communication requirements are mandated to increase the risk awareness of patients and physicians. These include black-box warnings, “Dear Health Care Provider” letters, U.S. Food and Drug Administration (FDA) Talk Papers, MedGuides, and Risk Minimization Action Plans (RiskMAPs). |
format | Online Article Text |
id | pubmed-10437540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-104375402023-08-21 Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy Projects, AMCP Special J Manag Care Pharm Commentary In the last 2 decades, health care management has been challenged by more aggressive therapy, the increased number of specialty medications, and more stringent guidelines to monitor adverse events or health risk. To promote patient safety, various communication requirements are mandated to increase the risk awareness of patients and physicians. These include black-box warnings, “Dear Health Care Provider” letters, U.S. Food and Drug Administration (FDA) Talk Papers, MedGuides, and Risk Minimization Action Plans (RiskMAPs). Academy of Managed Care Pharmacy 2012-04 /pmc/articles/PMC10437540/ /pubmed/22468736 http://dx.doi.org/10.18553/jmcp.2012.18.3.268 Text en Copyright © 2012, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Commentary Projects, AMCP Special Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy |
title | Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy |
title_full | Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy |
title_fullStr | Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy |
title_full_unstemmed | Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy |
title_short | Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy |
title_sort | implications of risk evaluation and mitigation strategy (rems) programs for managed care pharmacy |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437540/ https://www.ncbi.nlm.nih.gov/pubmed/22468736 http://dx.doi.org/10.18553/jmcp.2012.18.3.268 |
work_keys_str_mv | AT projectsamcpspecial implicationsofriskevaluationandmitigationstrategyremsprogramsformanagedcarepharmacy |